Co-Diagnostics Assets per Share
The Total Assets per Share of Co-Diagnostics (CODX) as of Oct 12, 2026 is 24.47 USD. In the previous year, Total Assets per Share was 63.30 USD — a change of -61.34% (lower).
Get this data via API
Financial Data API
Assets per Share
24.47USD
YoY
-61.34%
Last updated:
The Co-Diagnostics Assets per Share history
3 Years
10 Years
25 Years
Max
| YEAR | Assets per Share | YoY |
|---|---|---|
| 24.47USD | -61.34% | |
| 63.30USD | -32.86% | |
| 94.27USD | -22.56% | |
| 121.74USD | -23.09% | |
| 158.28USD | +124.65% | |
| 70.46USD | +3,115.65% | |
| 2.19USD | +42.63% | |
| 1.54USD | -66.69% | |
| 4.61USD | +259.80% | |
| 1.28USD | +249.35% | |
| 0.37USD | +42.75% | |
| 0.26USD | — |
Co-Diagnostics Stock analysis
Frequently Asked Questions about Co-Diagnostics stock
Total Assets per Share of Co-Diagnostics is 24.47 USD in 2025.
Total Assets per Share of Co-Diagnostics changed from 63.30 USD to 24.47 USD, representing a -61.34% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Total Assets per Share Co-Diagnostics since 2006 – with annual values, charts, and detailed analysis.
Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.
Other — Co-Diagnostics
All Key Metrics — Co-Diagnostics
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth